A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R

Starting soon · Phase 1

Conditions studied: Healthy Adult Participants

In brief

A study to evaluate the bioequivalence of DA-5230 compared to DA-5230-R

Key facts

Study ID

NCT07513649

Run by

Dong-A ST Co., Ltd.

People needed

60

Starts

2026-04-01

Expected to finish

2026-05-01

Last updated by the study team

2026-04-07

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy participants aged 19 to 55 years at the time of screening visit
• Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit

You may not qualify if…

• Participants who have received an investigational product in another clinical trial or a bioequivalence study within 6 months prior to the first dosing
• Participants deemed unsuitable for participation in this clinical trial by the investigator

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.